Literature DB >> 7723497

Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty.

N J Samani1, D S Martin, M Brack, J Cullen, A Chauhan, D Lodwick, A Harley, J D Swales, D P de Bono, A H Gershlick.   

Abstract

Early restenosis in over 30% of cases limits the benefits of percutaneous transluminal coronary angioplasty (PTCA). The mechanisms that underlie restenosis are uncertain, although experimental evidence suggests that the renin-angiotensin system is involved in the vascular response to angioplasty. An insertion(I)/deletion(D) polymorphism in the angiotensin-converting enzyme (ACE) gene, which influences plasma ACE level, has been associated with an increased risk of myocardial infarction in those with the DD genotype. To investigate whether this polymorphism influences the risk of restenosis after PTCA, 233 patients who underwent single-vessel angioplasty in the Subcutaneous Heparin and Angioplasty Restenosis Prevention (SHARP) study were genotyped for the I/D polymorphism and pre-PTCA, post-PTCA, and 4-month clinical and quantitative angiographic data were compared in the three genotype groups. The groups, (II 53, ID 117, and DD 63) were well matched for baseline clinical and both pre- and post-PTCA angiographic features. At 4-month follow-up there was no significant difference between the genotype groups with respect to any of the quantitative angiographic criteria of restenosis: minimal luminal diameter at the site of the angioplasty (DD 1.35 [SE 0.10] mm, ID/II 1.43 [0.05] mm, difference -0.08 [95% CI -0.30 to 0.14]), numbers of subjects with more than 50% diameter stenosis (DD 49%, ID/II 46%, relative risk 1.06 [0.79 to 1.43]), or the number of subjects with more than 50% loss of the acute diameter gain after PTCA (DD 54%, ID/II 43%, 1.26 [0.94 to 1.67]). Likewise, there was no difference in the number of subjects with angina or a positive exercise stress test. We conclude that, in patients undergoing elective PTCA, the I/D polymorphism in the ACE gene does not influence the extent of restenosis, and typing for the polymorphism will not be a useful predictor of risk before the procedure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7723497     DOI: 10.1016/s0140-6736(95)90756-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  11 in total

1.  The angiotensin converting enzyme gene in cardiovascular disease.

Authors:  M Caulfield; J Newell-Price
Journal:  Br Heart J       Date:  1995-09

2.  Increased risk for ischaemic events is related to combined RAS polymorphism.

Authors:  P P van Geel; Y M Pinto; A H Zwinderman; R H Henning; A J van Boven; J W Jukema; A V Bruschke; J J Kastelein; W H van Gilst
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

Review 3.  Genetic risk factors and restenosis after percutaneous coronary interventions.

Authors:  A Kastrati; J Dirschinger; A Schömig
Journal:  Herz       Date:  2000-02       Impact factor: 1.443

4.  Interleukin 1 receptor antagonist gene polymorphism and restenosis after coronary angioplasty.

Authors:  S E Francis; N J Camp; A J Burton; R M Dewberry; J Gunn; A Stephens-Lloyd; D C Cumberland; A Gershlick; D C Crossman
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

Review 5.  Angiotensin-converting enzyme inhibitors and coronary artery disease.

Authors:  J W Sayer; A D Timmis
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

Review 6.  Vascular injury in systemic sclerosis: angiotensin-converting enzyme insertion/deletion polymorphism.

Authors:  Cinzia Fatini; Serena Guiducci; Rosanna Abbate; Marco Matucci-Cerinic
Journal:  Curr Rheumatol Rep       Date:  2004-04       Impact factor: 4.592

7.  Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: meta-analysis of 16 studies.

Authors:  François Bonnici; Bernard Keavney; Rory Collins; John Danesh
Journal:  BMJ       Date:  2002-09-07

8.  Angiotensin converting enzyme DD genotype is associated with acute coronary syndrome severity and sudden cardiac death in Taiwan: a case-control emergency room study.

Authors:  Ying-Hsin Chen; Jui-Ming Liu; Ren-Jun Hsu; Sheng-Chuan Hu; Horng-Jyh Harn; Shee-Ping Chen; Jing-Ren Jeng; Chieh-Lin Wu; Jar-Yi Ho; Cheng-Ping Yu
Journal:  BMC Cardiovasc Disord       Date:  2012-02-15       Impact factor: 2.298

9.  Genetic polymorphism of angiotensin converting enzyme and risk of coronary restenosis after percutaneous transluminal coronary angioplasties: evidence from 33 cohort studies.

Authors:  Shen Wang; Yuxiang Dai; Lingling Chen; Zhibing Dong; Yunpeng Chen; Chenguang Li; Xin Zhong; Wenhui Lin; Jifu Zhang
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

Review 10.  Influence of the angiotensin converting enzyme insertion or deletion genetic variant and coronary restenosis risk: evidence based on 11,193 subjects.

Authors:  Yang Pan; Fang Wang; Qin Qiu; Ren Ding; Baolong Zhao; Hua Zhou
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.